Beam Therapeutics Inc.BEAMNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank88
3Y CAGR+9.5%
5Y CAGR+31.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+9.5%/yr
vs +74.2%/yr prior
5Y CAGR
+31.8%/yr
Recent deceleration
Acceleration
-64.6pp
Decelerating
Percentile
P88
Within normal range
vs 5Y Ago
4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $409.62M | +11.4% |
| 2024 | $367.56M | -16.0% |
| 2023 | $437.38M | +40.4% |
| 2022 | $311.59M | -19.5% |
| 2021 | $387.09M | +275.2% |
| 2020 | $103.18M | +88.9% |
| 2019 | $54.62M | +61.2% |
| 2018 | $33.87M | +478.1% |
| 2017 | $5.86M | - |